Skip to content
Search

Latest Stories

Nardil 15mg tablets likely to remain out of stock this year

Nardil (Phenelzine sulfate)15mg tablets are expected to continue to face supply disruptions this year.

Kyowa Kirin, the sole manufacturer of Nardil tablets has said no exact date was set as to when the product would be back in stock, however the availability issues were expected to last until 2021.


Despite supply issues amid delays, the manufacturer has confirmed that the tablets have not been discontinued.

The company has already informed the Department of Health and Social Care that due to manufacturing challenges, Nardil has been out of stock since Summer 2019.

Supplies of Phenelzine 15mg tablets may be available to order from the following specialist importers on an ‘unlicensed’ basis.

ImporterContact details 
Alium MedicalTel: 020 8238 6770

Email: enquiries@aliummedical.com

Chemys LimitedTel: 02085008497

Email: orders@chemys.co.uk

Clinigen Group PLCTel: 01932 824100

Email: ukcustomerservice@clinigengroup.com

Durbin PLCTel: 0208 869 6555

Email: Imports@durbin.co.uk

Ethigen LtdTel: 0800 019 7100

Email: specials@ethigen.co.uk

Mawdsley-Brooks & CoTel: 01302 553000

Email: customerservices@mawdsleys.co.uk

Target Healthcare UK LimitedTel: 08456 180036

Email: specials@target-healthcare.co.uk

Thistle Pharma LimitedTel: 0800 169 9765

Email: contactus@thistlepharma.com

WEP ClinicalTel: 0208 004 8185

Email: info@wepclinical.com

(The list of suppliers above is not exhaustive. Credit: PSNC)

Pharmacists have been advised to note that delivery lead-times may vary between companies.

An update from the NHS Specialist Pharmacy Service (SPS) on the shortage of Nardil states: “If there is potential for a patient maintained on Phenelzine 15mg tablets to run out of supply during this shortage, they should be urgently referred back to a mental health specialist for advice on ongoing clinical management.”

According to PSNC, where prescribing of an unlicensed import is considered appropriate by the prescriber, a prescription must be issued with the wording ‘Special Order’ next to the prescribed product to ensure that a pharmacy can dispense and be correctly reimbursed for a non-Part VIIIB special.

Any EPS or paper prescription issued must specify ‘Phenelzine 15mg tablets (Special Order)’ in order for the pharmacists to dispense and be reimbursed for supplying an unlicensed import.

If a prescription is issued for ‘Phenelzine 15mg tablets‘ without any ‘Special Order’ wording against it, a pharmacy contractor would only be reimbursed the list price of £22.50 for a pack of 100 based on the reference product Nardil.

Prescriptions for unlicensed imported products not listed in Part VIIIB of the Drug Tariff must be endorsed with the following…

  • Amount dispensed over pack size used
  • Invoice price per pack size from which the order was supplied less any discount or rebate
  • Manufacturers’/importers’ MHRA licence number
  • Batch number of the product supplied.

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less